Efficacy and Safety of New B Cell-Targeted Biologic Agent for the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
José Luís Gómez-UrquizaJosé Luis Romero-BéjarSara Chami-PeñaNora Suleiman MartosGuillermo A Cañadas-De la FuenteEsther MolinaBlanca Riquelme GallegoPublished in: Journal of clinical medicine (2023)
Belimumab and tabalumab therapies are effective and safe in the treatment of SLE, although tabalumab does not show sufficient statistical power. Advances in understanding the underlying mechanisms of SLE will be directed towards correlating clinical manifestations with specific pathogenic pathways and the development of precision medicine.